DHSG

ELEPHANT-trial

ELEPHANT-trialLogo ELEPHANT

EvaLuation of treatment and course of hypErParatHyreoidism related to end stAge reNal disease – a mulTicenter analysis.

Middels samenwerking tussen verschillende disciplines (chirurgie, nefrologie, transplantatie) en verschillende ziekenhuizen zorg dragen voor kwalitatief hoogwaardig onderzoek. Zowel retrospectief als prospectief streven wij optimale samenwerking.
ELEPHANT-1 What is the effect of PTx prior to or post kidney Tx on graft function?
Leading center: UMCG; R Pol

 

ELEPHANT-2 What is the effect of PTx compared to calcimimetics in the control of secondary HPT prior to kidney Tx?
Leading center: AMC; AF Engelsman

 

ELEPHANT-3 What is the effect of PTx compared to calcimimetics in the control of tertiary HPT post kidney Tx?
Leading center: EMC; TM van Ginhoven

 

ELEPHANT-4 What is the 30-day outcome and effectiveness of PTx in ESRD patients?
Leading center: UMCG; S Kruijff

 

ELEPHANT-5 Identifying predictors of spontaneous regression of hyperparathyroidism after kidney transplantation
Leading center: LUMC, A. Schepers

Een volledig overzicht van de verschillende ELEPHANT-trials vindt u in het linker menu

© 2018 Dutch Hyperparathyroid Study Group      Disclaimer